Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
View ORCID ProfileAlexander Neumann, Olena Ohlei, View ORCID ProfileFahri Küçükali, View ORCID ProfileIsabelle J Bos, View ORCID ProfileStephanie Vos, View ORCID ProfileDmitry Prokopenko, View ORCID ProfileBetty M Tijms, View ORCID ProfileUlf Andreasson, View ORCID ProfileKaj Blennow, View ORCID ProfileRik Vandenberghe, View ORCID ProfilePhilip Scheltens, View ORCID ProfileCharlotte E Teunissen, View ORCID ProfileSebastiaan Engelborghs, View ORCID ProfileGiovanni B Frisoni, Oliver Blin, Jill C Richardson, View ORCID ProfileRégis Bordet, Alberto Lleó, View ORCID ProfileDaniel Alcolea, View ORCID ProfileJulius Popp, View ORCID ProfileChristopher Clark, Gwendoline Peyratout, View ORCID ProfilePablo Martinez-Lage, View ORCID ProfileMikel Tainta, View ORCID ProfileRichard JB Dobson, View ORCID ProfileCristina Legido-Quigley, View ORCID ProfileChristine Van Broeckhoven, View ORCID ProfileRudolph E Tanzi, View ORCID ProfileMara ten Kate, View ORCID ProfileChristina M Lill, View ORCID ProfileFrederik Barkhof, View ORCID ProfileSimon Lovestone, View ORCID ProfileJohannes Streffer, View ORCID ProfileHenrik Zetterberg, View ORCID ProfilePieter Jelle Visser, View ORCID ProfileKristel Sleegers, View ORCID ProfileLars Bertram, EMIF-AD & ADNI study group
doi: https://doi.org/10.1101/2022.08.02.22278185
Alexander Neumann
1Complex Genetics of Alzheimer’s Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Olena Ohlei
3Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lübeck, Germany
Fahri Küçükali
1Complex Genetics of Alzheimer’s Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Isabelle J Bos
4Netherlands Institute for Health Services Research, Utrecht, Netherlands
Stephanie Vos
5Alzheimer Centrum Limburg, Maastricht University, Maastricht, Netherlands
Dmitry Prokopenko
6Genetics and Aging Unit and McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA
Betty M Tijms
7Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
Ulf Andreasson
8Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden
9Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
Kaj Blennow
8Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden
9Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
Rik Vandenberghe
10Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium
11Neurology Service, University Hospital Leuven, Leuven, Belgium
Philip Scheltens
7Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
Charlotte E Teunissen
12Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam
Sebastiaan Engelborghs
13Department of Neurology and Memory Clinic, Universitair Ziekenhuis Brussel (UZ Brussel) and Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Giovanni B Frisoni
14Memory Center, Department of Rehabilitation and Geriatrics, Geneva University and University Hospitals, Geneva, Switzerland
Oliver Blin
15Clinical Pharmacology & Pharmacovigilance Department, Marseille University Hospital, Marseille, France
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Jill C Richardson
16Neurosciences Therapeutic Area, GlaxoSmithKline R&D, Stevenage, United Kingdom
Régis Bordet
17Neuroscience & Cognition, CHU de Lille, University of Lille, Inserm, France
Alberto Lleó
18Memory Unit, Neurology Department, Hospital de Sant Pau, Barcelona and Centro de Investigación Biomédica en Red en enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
Daniel Alcolea
18Memory Unit, Neurology Department, Hospital de Sant Pau, Barcelona and Centro de Investigación Biomédica en Red en enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
Julius Popp
19Department of Geriatric Psychiatry, University Hospital of Psychiatry Zürich, Zürich, Switzerland
Christopher Clark
19Department of Geriatric Psychiatry, University Hospital of Psychiatry Zürich, Zürich, Switzerland
Gwendoline Peyratout
20Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland
Pablo Martinez-Lage
21Center for Research and Advanced Therapies, CITA—Alzheimer Foundation, San Sebastian, Spain
Mikel Tainta
21Center for Research and Advanced Therapies, CITA—Alzheimer Foundation, San Sebastian, Spain
22Zumarraga Hospital, Osakidetza, Integrated Health Organization (OSI) Goierri-Urola Garia, Basque Country, Spain
Richard JB Dobson
23Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, Boston, United Kingdom
24NIHR BioResource Centre Maudsley, NIHR Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust (SLaM) & Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King’s College London, London, United Kingdom
25Health Data Research UK London, University College London, London, United Kingdom
26Institute of Health Informatics, University College London, London, United Kingdom
27The National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London, London, United Kingdom
Cristina Legido-Quigley
28Steno Diabetes Center, Copenhagen, Denmark
Christine Van Broeckhoven
29Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Rudolph E Tanzi
6Genetics and Aging Unit and McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA
Mara ten Kate
30Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, Netherlands
31Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands
Christina M Lill
3Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lübeck, Germany
32Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
33Ageing Epidemiology Research Unit, School of Public Health, Imperial College, London, United Kingdom
Frederik Barkhof
34Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands
35Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, United Kingdom
Simon Lovestone
36Janssen Medical Ltd, United Kingdom
37Department of Psychiatry, University of Oxford, Oxford, United Kingdom at the time of the study
Johannes Streffer
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
38AC Immune SA, Lausanne, Switzerland
39Janssen R&D, LLC, Beerse, Belgium at the time of study
Henrik Zetterberg
8Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden
40Department of Neurodgenerative Disease, UCL Institute of Neurology, London, United Kingdom
9Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
41UK Dementia Research Institute, University College London, London, United Kingdom
42Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China
Pieter Jelle Visser
5Alzheimer Centrum Limburg, Maastricht University, Maastricht, Netherlands
30Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, Netherlands
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Kristel Sleegers
1Complex Genetics of Alzheimer’s Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Lars Bertram
3Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lübeck, Germany
43Centre for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted August 09, 2022.
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Alexander Neumann, Olena Ohlei, Fahri Küçükali, Isabelle J Bos, Stephanie Vos, Dmitry Prokopenko, Betty M Tijms, Ulf Andreasson, Kaj Blennow, Rik Vandenberghe, Philip Scheltens, Charlotte E Teunissen, Sebastiaan Engelborghs, Giovanni B Frisoni, Oliver Blin, Jill C Richardson, Régis Bordet, Alberto Lleó, Daniel Alcolea, Julius Popp, Christopher Clark, Gwendoline Peyratout, Pablo Martinez-Lage, Mikel Tainta, Richard JB Dobson, Cristina Legido-Quigley, Christine Van Broeckhoven, Rudolph E Tanzi, Mara ten Kate, Christina M Lill, Frederik Barkhof, Simon Lovestone, Johannes Streffer, Henrik Zetterberg, Pieter Jelle Visser, Kristel Sleegers, Lars Bertram, EMIF-AD & ADNI study group
medRxiv 2022.08.02.22278185; doi: https://doi.org/10.1101/2022.08.02.22278185
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Alexander Neumann, Olena Ohlei, Fahri Küçükali, Isabelle J Bos, Stephanie Vos, Dmitry Prokopenko, Betty M Tijms, Ulf Andreasson, Kaj Blennow, Rik Vandenberghe, Philip Scheltens, Charlotte E Teunissen, Sebastiaan Engelborghs, Giovanni B Frisoni, Oliver Blin, Jill C Richardson, Régis Bordet, Alberto Lleó, Daniel Alcolea, Julius Popp, Christopher Clark, Gwendoline Peyratout, Pablo Martinez-Lage, Mikel Tainta, Richard JB Dobson, Cristina Legido-Quigley, Christine Van Broeckhoven, Rudolph E Tanzi, Mara ten Kate, Christina M Lill, Frederik Barkhof, Simon Lovestone, Johannes Streffer, Henrik Zetterberg, Pieter Jelle Visser, Kristel Sleegers, Lars Bertram, EMIF-AD & ADNI study group
medRxiv 2022.08.02.22278185; doi: https://doi.org/10.1101/2022.08.02.22278185
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12139)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4035)
- Geriatric Medicine (380)
- Health Economics (671)
- Health Informatics (2607)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3804)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6473)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (52)
- Transplantation (185)
- Urology (165)